Effect of Angiotensin-Converting Enzyme Inhibitors and/or Angiotensin Receptor Blockers on the Prevention of Death in Patients with Type 2 Diabetes and Undetermined Nephropathy : Five-Year Survival Data

Converting Enzyme ◽

Angiotensin Receptor ◽

Impact of angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers on renal and mortality outcomes in people with Type 2 diabetes and proteinuria

Diabetic Medicine ◽

10.1111/dme.14107 ◽

2019 ◽

Vol 37 (1) ◽

pp. 44-52 ◽

Cited By ~ 1

Author(s):

C. I. Coleman ◽

E. R. Weeda ◽

A. Kharat ◽

B. Bookhart ◽

W. L. Baker

Keyword(s):

Type 2 Diabetes ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Angiotensin converting enzyme inhibitors or angiotensin receptor blockers in nephropathy from type 2 diabetes

Current Hypertension Reports ◽

10.1007/s11906-002-0005-6 ◽

2002 ◽

Vol 4 (3) ◽

pp. 185-190 ◽

Cited By ~ 12

Author(s):

Jay Garg ◽

George L. Bakris

Keyword(s):

Type 2 Diabetes ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers for Prevention of Type 2 Diabetes

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2005.05.051 ◽

2005 ◽

Vol 46 (5) ◽

pp. 821-826 ◽

Cited By ~ 298

Author(s):

Hussam Abuissa ◽

Philip G. Jones ◽

Steven P. Marso ◽

James H. O’Keefe

Keyword(s):

Type 2 Diabetes ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

1150-P: Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers on Renal Outcomes in Patients with Type 2 Diabetes and Proteinuria

Diabetes ◽

10.2337/db19-1150-p ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 1150-P

Author(s):

CRAIG I. COLEMAN ◽

ERIN R. WEEDA ◽

AKSHAY A. KHARAT ◽

BRAHIM BOOKHART ◽

WILLIAM L. BAKER

Keyword(s):

Type 2 Diabetes ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Angiotensin-Converting Enzyme Inhibitors Reduce Albuminuria More than Angiotensin Receptor Blockers in Patients with Type 2 Diabetes

Endocrine Practice ◽

10.4158/ep12272.or ◽

2013 ◽

Vol 19 (4) ◽

pp. 579-586 ◽

Cited By ~ 1

Author(s):

Nasreen AL-Sayed ◽

Tianming Gao ◽

Brian Wells ◽

Changhong Yu ◽

Robert Zimmerman

Keyword(s):

Type 2 Diabetes ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Angiotensin-Converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers for the Treatment of Hypertension in Adults With Type 2 Diabetes: Why We Favour Angiotensin Receptor Blockers

Canadian Journal of Diabetes ◽

10.1016/j.jcjd.2017.11.006 ◽

2018 ◽

Vol 42 (2) ◽

pp. 118-123 ◽

Cited By ~ 3

Author(s):

Thomas A. Mavrakanas ◽

Mark L. Lipman

Keyword(s):

Type 2 Diabetes ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Treatment Of Hypertension ◽

Response to the Letter to the Editor From Dr Kawada, “Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors for the Treatment of Hypertensive Patients With Type 2 Diabetes Mellitus”

Canadian Journal of Diabetes ◽

10.1016/j.jcjd.2019.08.004 ◽

2020 ◽

Vol 44 (1) ◽

pp. 5

Author(s):

Thomas A. Mavrakanas ◽

Mark L. Lipman

Keyword(s):

Diabetes Mellitus ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Hypertensive Patients ◽

Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors for the Treatment of Hypertensive Patients With Type 2 Diabetes Mellitus

Canadian Journal of Diabetes ◽

10.1016/j.jcjd.2019.01.001 ◽

2020 ◽

Vol 44 (1) ◽

pp. 4 ◽

Cited By ~ 1

Author(s):

Tomoyuki Kawada

Keyword(s):

Diabetes Mellitus ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Hypertensive Patients ◽

Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers for Prevention of Type 2 Diabetes: A Meta-analysis of Randomized Clinical Trials

Yearbook of Endocrinology ◽

10.1016/s0084-3741(08)70292-0 ◽

2006 ◽

Vol 2006 ◽

pp. 73-74

Author(s):

J.L. Leahy

Keyword(s):

Randomized Clinical Trials ◽

Enzyme Inhibitors ◽

Meta Analysis ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Comparing the effect of Angiotensin-Converting Enzyme Inhibitors versus Angiotensin Receptor Blockers in heart failure patients with type 2 diabetes mellitus: a systematic review

Bali Medical Journal ◽

10.15562/bmj.v8i3.1534 ◽

2019 ◽

Vol 8 (3) ◽

pp. 757

Author(s):

Ratih Puspita Febrinasari ◽

Bambang Irawan Martohusodo ◽

Erna Kristin ◽

Ricvan Dana Nindrea ◽

Iwan Dwiprahasto

Keyword(s):

Diabetes Mellitus ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Heart Failure Patients ◽